Time-kill curves were used to assess the relative in vitro efficacy of the early interaction of three semisynthetic penicillins with two aminoglycosides against 48 Enterobacteriaceae strains. The most efficacious combinations were piperacillin plus amikacin, which demonstrated synergism (>2 logs of increased kill after 7 h of incubation) against 43 of 48 (901%) strains, and piperacillin plus gentamicin, which exhibited synergism against 25 of 48 (52%) strains. With the combinations of carbenicillin or ticarcdillin plus amikacin or gentamicin, early synergistic killing was demonstrated against only 12 to 29% of the strains.
Semisynthetic penicillins such as ampicillin, carbenicillin, and ticarcillin have been used for several years in the therapy of severe gramnegative baciliary infections. Piperacillin is a new semisynthetic penicillin which has demonstrated greater in vitro activity than carbenicillin or ticarcillin against Pseudomonas aeruginosa and members of the Enterobacteriaceae (1, 5, 13, 15, 16, 19, 20) . Piperacillin exhibits substantial activity against many strains of gram-negative bacteria which are resistant to carbenicillin and ticarcillin, including Enterobacter spp. and Klebsiella pneumoniae (4, 11) . In addition, several investigators have demonstrated in vitro synergism between piperacillin and aminoglycosides against members of the Enterobacteriaceae (5, 8, 12) , Pseudomonas aeruginosa (2, 8, 13, 17) , and other nonfermentative, gramnegative bacteria (3) .
In this in vitro study, time-kill curves during 7 h of incubation were used to assess the early interaction between three semisynthetic penicillins (carbenicillin, ticarcillin, and piperacillin) and two aminoglycoside antibiotics (gentamicin and amikacin) against 48 Antibiotic synergism. The interaction between each of the three semisynthetic penicillins and each of the two aminoglycosides was evaluated by time-kill curves in Mueller-Hinton broth as described previously (6) . A starting inoculum of 105 organisms per ml was prepared by appropriate dilution of an overnight broth culture. The concentrations of antibiotics in the flasks were selected to be at or below the MIC for each drug and within a clinically achievable range for each drug:
:125 pg/ml for each of the penicillins, s4 pg/ml for gentamicin, and <8 .g/ml for amikacin. The culture flasks (final volume, 20 ml) were incubated without agitation at 35°C, and 0.5-mi samples were removed at 0, 4, and 7 h for determination of colony counts with 10-fold serial dilutions. Early synergy is herein defined as a decrease of 100-fold or more in the number of EARLY SYNERGISM AGAINST ENTEROBACTERIACEAE 903 viable organisms after 7 h of incubation in the presence of the combination as compared with the more effective of the two antibiotics alone.
We chose to compare drug effectiveness at 7 h because of regrowth of the organisms beyond the 7-h sample point, a phenomenon which has been noted by other investigators (5, 7, 9, 14) . In our laboratory, a survey of 32 antibiotic combinations against six Enterobacteriaceae strains demonstrated that 21 (66%) combinations exhibited substantial regrowth of the organism between the 7-h and the 24-h sampling times. In addition, determination of the stability of the semisynthetic penicillins in the flasks was performed by American Cyanamid Co., a division of Lederle Laboratories, by an agar well diffusion biological assay with P. aeruginosa as the test organism. Incubation with each of four Enterobacteriaceae strains resulted in a marked decline in activity of each semisynthetic penicillin, often to levels of <2 .gIml after 7 h ( Table 1 ). The degradation of semisynthetic penicillins is probably due to ,B-lactamase activity, since no significant inactivation occurred in sterile Mueller-Hintdh broth. Therefore, it appears that loss of semisynthetic penicillin activity may account for the regrowth of the Enterobacteriaceae strains after 7 h.
RESULTS
The interaction between each of the three semisynthetic penicillins (carbenicillin, ticarcillin, and piperacillin) and two aminoglycosidic aminocyclitols (gentamicin and amikacin) was evaluated against 12 strains each of E. coli, K. pneumoniae, and Enterobacter and Proteus spp. Most of the 48 strains selected for evaluation of synergism were resistant to multiple antibiotics. Of the selected strains, 81% were resistant to ¢125 pLg of carbenicillin and ticarcillin per ml, 40% were resistant to :125 Fg of piperacillin per ml, and 52% were resistant to >4 ,ug of gentamicin per ml. Only 8% of the strains were resistant to :8 ,g of amikacin per ml. Figure 1 shows a time-kill curve demonstrating early synergistic interaction between two of six penicillin-aminoglycoside combinations (amikacin plus piperacillin and gentamicin plus piperacillin) against an E. coli strain resistant to all three penicillins, mildly resistant to amikacin, and susceptible to gentamicin.
Overall, the most efficacious combination against the Enterobacteriaceae was piperacillin plus amikacin, which exhibited early synergy against 43 of 48 strains tested, followed by the combination of piperacillin plus gentamicin, which exhibited early synergism against 25 of 48 strains (Table 2 ). In contrast, ,2 logs of increased kill was obtained at 7 h with the combi- For most peniciflin-aminoglycoside combinations, the susceptibilities of our strgins to the individual antibiotics appeared to be determinants of the bacterial interaction of the drugs in the combination (Table 3) . For example, early synergism was obtained with carbenicillin or ticarcillin plus gentamicin or amikacin against only 11% of the strains resistant to either semisynthetic penicillin or the respective aminoglycoside or both. For the combination piperacillin plus gentamicin, all three strains which were resistant to >125 ,ug of piperacillin per ml and susceptible to -4 ,g of gentamicin per ml were synergistically killed at 7 h, whereas only 3 of 25 strains were synergistically killed when the strain was resistant to gentamicin. However, the most efficacious combination, piperacillin plus amikacin, produced early synergim against 91% of the strains resistant to one or both drugs in the combination.
DISCUSSION
Time-kill studies against multidrug-resistant Enterobacteriaceae strains demonstrated that the addition of piperacillin to either amikacin or gentamicin was more potent and more likely to produce early synergistic killing than the addition of carbenicillin or ticarcillin to either amino- ance to one or both drugs was associated with a low probability that synergism would be obtained.
In summary, piperacillin exhibits in vitro advantages over earlier semisynthetic penicillins against Enterobacteriaceae. In addition to its enhanced activity as compared with carbenicillin and ticarcillin against many gram-negative bacilli, this agent appears to be especially potent in producing early synergistic killing when used in combination with aminoglycosides, especially amikacin.
